Ecron Acunova Announces Key Leadership Change – Marty Boom appointed as Managing Director
Ecron Acunova, a subsidiary of TAKE Solutions and specialized provider of clinical services to Pharma & Biotech companies, announced the appointment of Marty Boom as Managing Director.
Mr. Boom takes over this position from his former role as Head of Operations of TAKE Solutions’ Life Sciences brand Navitas, where he made significant contributions to the growth of the organization with his leadership spanning both the US and India geographies. Mr. Boom has rich experience in managing diverse global teams and has led global business improvement assignments for companies like Bayer HealthCare, Pfizer, Johnson & Johnson, Roche, and many others in most areas of Pharmaceutical Drug Development and Supply Chain. Mr. Boom will be based at the Headquarters in Frankfurt, Germany.
About Ecron Acunova
Ecron Acunova (www.ecronacunova.com ) is a full service CRO with predominant presence in Europe and Asia with 30 years of track record. EA offers full-service clinical research including clinical operations, data management, biostatistics, pharmacovigilance, PK/PD services and central lab to pharma, biotech, medical device, nutrition and diagnostic companies.
Ecron Acunova is a wholly owned subsidiary of TAKE Solutions Ltd .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
NY-CITI-PRIVATE-BANK18.6.2018 16:03 | pressemeddelelse
Citi Private Bank Congratulates Fernando Alonso on the 24 Hours of Le Mans Win
MI-INTEVA-PRODUCTS18.6.2018 15:33 | pressemeddelelse
Inteva Products Receives Top Innovation Award for Revolutionary Stitching Process
PROCTER-&-GAMBLE18.6.2018 14:27 | pressemeddelelse
P&G Advances Systemic Change for Gender Equality in Advertising at 2018 Cannes Lions Festival of Creativity
NY-NORSK-TITANIUM18.6.2018 14:02 | pressemeddelelse
Norsk Titanium Marks Milestone in U.S. Production
MA-AVEDRO18.6.2018 14:02 | pressemeddelelse
Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus
VERTEX-PHARMACEUTICALS18.6.2018 13:02 | pressemeddelelse
Vertex Announces Long-Term Access Agreement in Sweden for Cystic Fibrosis Medicine ORKAMBI® (lumacaftor/ivacaftor)
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum